Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

Complete title: SC-9002: A Phase II Clinical Trial of Induction Chemotherapy Regimen Gemcitabine, Paciltaxel, and Oxaliplatin (GemPOx) Followed by a Single Cycle of High Dose Chemotherapy (HDC) and Autologous Hematopoeitic Stem Cell Rescue (AuHSCR) for patients with…

Research Study Number SC-9002
Principal Investigator Sarah Leary
Phase II

Research Study Description

This study will look to see how well patients with relapsed or recurrent intracranial germ cell tumors respond to the new combination of chemotherapy (in induction)of Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) followed by consolidation chemotherapy and autologous stem cell rescue.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number SC-9002
Contact Advanced Therapeutics Study Line
Telephone 206/987-2553

Keywords: Pediatric Cancers, Miscellaneous; Solid Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials